Lipid metabolism and inflammation modulated by Vitamin D in liver of diabetic rats

Cardiac metabolism, inflammation, and peroxisome proliferator-activated receptors modulated by 1,25-dihydroxyvitamin D3 in diabetic rats

(2014) Ting-I Lee et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome

(2013) Eun-Jung Rhee et al.   ENDOCRINE JOURNAL

Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease

(2013) K.L. Jablonski et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Fenofibrate lowers lipid accumulation in myotubes by modulating the PPARα/AMPK/FoxO1/ATGL pathway

(2012) Wei-Lu Chen et al.   BIOCHEMICAL PHARMACOLOGY

Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes

(2012) Erik Salum et al.   Cardiovascular Diabetology

Vitamin D and Cardiovascular Risk

(2012) Shweta R. Motiwala et al.   CURRENT HYPERTENSION REPORTS

Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism

(2012) Yi Yin et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity

(2012) Luis A. Videla et al.   PPAR Research

Does vitamin D deficiency contribute to increased rates of cardiovascular disease and type 2 diabetes in African Americans?

(2011) Susan S Harris   AMERICAN JOURNAL OF CLINICAL NUTRITION

Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001–2006

(2011) Vijay Ganji et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

PPARα Expression Protects Male Mice from High Fat–Induced Nonalcoholic Fatty Liver

(2011) Mohamed A. Abdelmegeed et al.   JOURNAL OF NUTRITION

Vitamin D: Evolutionary, Physiological and Health Perspectives

(2010) Michael F. Holick   CURRENT DRUG TARGETS

Vitamin D and Cardiovascular Disease: A Novel Agent for Reducing Cardiovascular Risk?

(2010) Panagiotis Anagnostis et al.   Current Vascular Pharmacology

Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IκBα/NF-κB, MAPKs, and mitochondria-dependent pathways: Prophylactic role of arjunolic acid

(2010) Prasenjit Manna et al.   FREE RADICAL BIOLOGY AND MEDICINE

Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine–choline-deficient diet

(2010) Karen M Kassel et al.   LABORATORY INVESTIGATION

Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers

(2009) Armin Zittermann et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population

(2008) M. L. Melamed et al.   ARCHIVES OF INTERNAL MEDICINE

Inhibition of CCR2 Ameliorates Insulin Resistance and Hepatic Steatosis in db/db Mice

(2008) Yukinori Tamura et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

22nd Marabou Symposium: the changing faces of vitamin D

(2008) W Philip T James   NUTRITION REVIEWS

Role of vitamin D in the pathogenesis of type 2 diabetes mellitus

(2007) X. Palomer et al.   DIABETES OBESITY & METABOLISM